3.3500
-0.0100
(-0.30%)
As of 11:14:44 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-40,489.0000
-38,434.0000
-54,337.0000
-37,619.0000
-25,739.0000
Investing Cash Flow
44,387.0000
37,786.0000
33,023.0000
-47,895.0000
-49,048.0000
Financing Cash Flow
-7,512.0000
7,580.0000
867.0000
-4,172.0000
188,814.0000
End Cash Position
21,398.0000
27,225.0000
20,293.0000
40,740.0000
130,426.0000
Interest Paid Supplemental Data
182.0000
2,359.0000
4,112.0000
4,437.0000
5,050.0000
Capital Expenditure
--
--
-416.0000
--
-677.0000
Issuance of Capital Stock
1,105.0000
14,117.0000
5,842.0000
--
193,222.0000
Issuance of Debt
--
--
--
--
891.0000
Free Cash Flow
-40,489.0000
-38,434.0000
-54,753.0000
-37,619.0000
-26,416.0000
12/31/2020 - 8/1/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RIGL Rigel Pharmaceuticals, Inc.
17.21
+0.58%
AGEN Agenus Inc.
3.1299
-0.80%
ATNF 180 Life Sciences Corp.
1.4500
-2.68%
CLDX Celldex Therapeutics, Inc.
23.72
-2.47%
LPTX Leap Therapeutics, Inc.
3.0800
-0.65%
CYCC Cyclacel Pharmaceuticals, Inc.
0.3990
+2.05%
PRLD Prelude Therapeutics Incorporated
1.0201
-0.96%
INKT MiNK Therapeutics, Inc.
0.7370
-5.37%
TENX Tenax Therapeutics, Inc.
6.34
+2.92%
APTO Aptose Biosciences Inc.
0.2064
-2.41%